Clinical context

Visual acuity alone is insufficient when judging corneal disease or surgery. Topography and tomography, surface regularity, biomechanics, endothelial cell density, quality of vision and stability all matter. After refractive procedures, epithelial healing, dry eye, haze, ectasia and the need for enhancement should be assessed separately.

What was studied

Visual acuity does not fully describe optical quality after LASIK; spherical aberration and coma may affect contrast and night vision. In this prospective randomized fellow-eye study, 30 patients with myopia or myopic astigmatism received ray-tracing-guided Wavelight Plus in one eye and wavefront-optimized LASIK in the other. At three months, investigators compared changes in total higher-order-aberration RMS, primary spherical aberration, coma and trefoil over a 6-mm zone.

How the evidence was produced

Randomization reduces the influence of known and unknown confounders and makes comparisons between interventions more reliable. Readers should still examine sequence generation, allocation concealment, masking of outcome assessors, the prespecified primary endpoint, losses to follow-up and intention-to-treat analysis. These details determine how confidently an observed difference can be attributed to the intervention.

Key result Mean total HOA RMS change was 0.00±0.15 µm after ray-tracing treatment, P=.758, and 0.11±0.12 µm after wavefront-optimized LASIK, P<.001. Spherical aberration changed by −0.07±0.13 µm, P=.012, versus +0.06±0.09 µm, P<.001. Coma and trefoil changed by 0.02±0.15 and −0.02±0.10 µm after Wavelight Plus; corresponding wavefront-optimized changes were 0.10±0.13 µm, P<.001, and 0.02±0.06 µm, P=.058. With baseline HOA RMS above 0.30 µm, ray tracing produced lower final total HOAs in all 13 patients; below that threshold, it did so in 12 of 17, 70.6%.

How to interpret the result

The fellow-eye design controls many patient-level differences and shows an early optical advantage for individualized ray tracing. Lower measured aberrations do not automatically mean better subjective vision: the abstract does not report contrast sensitivity, halos, night driving or satisfaction. Baseline-HOA subgroups were small and appear exploratory. The method may be particularly relevant when preoperative aberrations are elevated, but use also depends on measurement quality, tear-film stability and registration reproducibility.

Clinical applicability

The study may refine technique selection and informed discussion, but its conclusions depend on baseline corneal shape, stromal thickness, equipment, nomogram and surgeon experience. Applicability requires comparison of these factors and attention to variability, uncommon complications and follow-up duration rather than mean values alone.

Limitations

Only 30 patients were followed for three months, so uncommon adverse events and late stability cannot be assessed. Fellow eyes are correlated and require paired statistics. Masking, side allocation and comparability of optical zones and ablation depth need confirmation. Micrometer differences in HOA should be connected to patient-reported outcomes. Verify registration and the primary endpoint, power calculation, attrition, centration, aberrometry repeatability, dry-eye outcomes, refractive accuracy, adverse events, funding and conflicts.

What to verify in the source

Use the DOI below to verify complete methods, result tables, funding and conflicts of interest.